Pilot and feasibility grants for diabetes and obesity research announcedSep. 15, 2015, 3:06 PM
The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of Pilot and Feasibility Grants in the following areas:
Translational or behavioral science research (Type II translational research) related to diabetes or obesity; this grant mechanism is open to junior faculty members, investigators from other fields wishing to bring their expertise to diabetes or obesity-related research, and investigators currently conducting diabetes-related research who are proposing a new research direction. For the purpose of this announcement, Type II translation is defined as research focused on translating interventions/ approaches that have clearly demonstrated efficacy into real world health care settings, communities and populations at risk.
Basic or clinical research related to diabetes, metabolism, or obesity; this grant mechanism is open to junior faculty members, investigators from other fields wishing to bring their expertise to diabetes- or obesity-related research, and investigators currently conducting diabetes-related research who are proposing a new research direction.
Diabetes- or obesity-related pilot studies that utilize one of these Vanderbilt resources: VICB High-Throughput Screening Facility, BioVU or the Mass Spectrometry Research Center; this grant mechanism is open to any Vanderbilt faculty member.
The deadline for application for all three types of Pilot and Feasibility Grants is Jan. 15, 2016. Printed copies of applications may be delivered any time the week of Jan. 18. Investigators can apply to one or more funding mechanisms. The monies allocated will be from $30-$50,000 per year for 1 to 2 years as decided by the application review panel. The grant template and additional program information is available at the websites above.
A budget is not submitted until the project is funded.